Sort
16,179 grants matching “malaria”
Naturally Acquired Immunity to Malaria during the Epidemiologic Transition in Ken
$638,461James Walter Kazura · Case Western Reserve University · R01 · FY2011 · AI
Evaluating the role of P53 pathways in malaria
$638,439Tuan Manh Tran · Indiana University Indianapolis · R01 · FY2021 · AI
Plasmodium vivax Erythrocyte Invasion Mechanisms and Humoral Immune Response in Duffy Negative Africans
$638,275Eugenia Lo · University Of North Carolina Charlotte · R01 · FY2023 · AI
ICEMR Mali- Administrative Core
$638,273Seydou Doumbia · Univ Of Sciences, Tech & Tech Of Bamako · U19 · FY2019 · AI
Diversity of Host Pathogen Interactions
$638,258Samuel I. Miller · University Of Washington · U54 · FY2012 · AI
Pathogenesis of falciparum malaria in infancy
$638,237Seattle Biomedical Research Institute · R01 · FY2003 · AI
Redefining thermal suitability for urban malaria transmission in the context of humidity
$638,235Courtney Murdock · Cornell University · R01 · FY2023 · AI
Health Professionals Education Partnership Initiative Ethiopia
$638,000Miliard Derbew · Addis Ababa University · R25 · FY2018 · TW
Genetic Approaches to Lipid Metabolism
$637,837John E. Cronan · University Of Illinois At Urbana-Champaign · R01 · FY2010 · AI
Virus-like Particle based malaria vaccines targeting vulnerable epitopes in the circumsporozoite protein
$637,784Bryce C Chackerian · University Of New Mexico Health Scis Ctr · R01 · FY2023 · AI
Health Professions Education and training for strengthening the health system and services in Uganda
$637,724Sarah Kiguli · Makerere University College Of Health Sciences · R25 · FY2018 · TW
Synthetic rescue of antigen-driven T cells and alloimmunity
$637,613Jonathan A Soboloff · Temple Univ Of The Commonwealth · R01 · FY2021 · AI
Synthetic rescue of antigen-driven T cells and alloimmunity
$637,613Jonathan A Soboloff · Temple Univ Of The Commonwealth · R01 · FY2022 · AI
Synthetic rescue of antigen-driven T cells and alloimmunity
$637,613Jonathan A Soboloff · Temple Univ Of The Commonwealth · R01 · FY2023 · AI
Novel Multiple-Stage Active Antimalarials
$637,460Kevin A Reynolds · Portland State University · R01 · FY2020 · AI
Clinical safety and pharmacokinetic studies of intravaginal rings releasing multiple antiretrovirals
$637,265Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R44 · FY2016 · HD
IRS insecticides for malaria control and child neurodevelopment in South Africa
$637,076Brenda Eskenazi · University Of California Berkeley · R01 · FY2012 · ES
Host Immune Responses to Antigens of Malaria Parasites
$636,717Carole Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Defining the targets of broad intervention antimalarial agents
$636,473Elizabeth A Winzeler · University Of California, San Diego · R01 · FY2016 · AI
Immuno-Genetic Epidemiology of Complex Malaria in India
$636,399Matthew Thomas · New York University · U19 · FY2015 · AI
Multifidelity and multiscale modeling of the spleen function in sickle cell disease with in vitro, ex vivo and in vivo validations
$636,323George Karniadakis · Brown University · R01 · FY2023 · HL
Lead optimization of DHODH inhibitors for malaria
$636,297Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2013 · AI
Integrative Multiomics to Probe Interactions of the Gut Microbiome with Malaria Pathogenesis and Antimalarial Pharmacokinetics in Humans
$636,193Matthew Michael Ippolito · Johns Hopkins University · R01 · FY2025 · AI
Immune responses to HIV virus immunization - Project 2
$636,026Margaret Juliana McElrath · Seattle Biomedical Research Institute · U19 · FY2017 · AI
Cultureâspecific neurodevelopmental assessment of HIV-affected children
$635,804Michael Joseph Boivin · Michigan State University · R01 · FY2023 · HD